These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25028513)

  • 1. β-III Tubulin fragments inhibit α-synuclein accumulation in models of multiple system atrophy.
    Suzuki Y; Jin C; Iwase T; Yazawa I
    J Biol Chem; 2014 Aug; 289(35):24374-82. PubMed ID: 25028513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of neuronal α-synuclein to β-III tubulin and accumulation in a model of multiple system atrophy.
    Nakayama K; Suzuki Y; Yazawa I
    Biochem Biophys Res Commun; 2012 Jan; 417(4):1170-5. PubMed ID: 22227187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy.
    Nakayama K; Suzuki Y; Yazawa I
    Am J Pathol; 2009 Apr; 174(4):1471-80. PubMed ID: 19286568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
    Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
    Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates.
    Yamaguchi H; Nishimura Y; Matsuse D; Sekiya H; Masaki K; Tanaka T; Saiga T; Harada M; Kira YI; Dickson DW; Fujishima K; Matsuo E; Tanaka KF; Yamasaki R; Isobe N; Kira JI
    Brain Behav Immun; 2024 Oct; 121():122-141. PubMed ID: 38986725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein accumulation reduces GABAergic inhibitory transmission in a model of multiple system atrophy.
    Ito H; Nakayama K; Jin C; Suzuki Y; Yazawa I
    Biochem Biophys Res Commun; 2012 Nov; 428(3):348-53. PubMed ID: 23098910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
    Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy.
    Ubhi K; Rockenstein E; Mante M; Patrick C; Adame A; Thukral M; Shults C; Masliah E
    Neuroreport; 2008 Aug; 19(13):1271-6. PubMed ID: 18695506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C triggers neuronal degeneration in a model of multiple system atrophy.
    Suzuki Y; Jin C; Yazawa I
    Am J Pathol; 2014 Mar; 184(3):790-9. PubMed ID: 24405769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein.
    Krejciova Z; Carlson GA; Giles K; Prusiner SB
    Acta Neuropathol Commun; 2019 May; 7(1):81. PubMed ID: 31109379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic approaches in multiple system atrophy.
    Palma JA; Kaufmann H
    Clin Auton Res; 2015 Feb; 25(1):37-45. PubMed ID: 24928797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
    Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
    Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
    Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E
    J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
    Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration.
    Yazawa I; Giasson BI; Sasaki R; Zhang B; Joyce S; Uryu K; Trojanowski JQ; Lee VM
    Neuron; 2005 Mar; 45(6):847-59. PubMed ID: 15797547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.
    Dhillon JS; Trejo-Lopez JA; Riffe C; Levites Y; Sacino AN; Borchelt DR; Yachnis AY; Giasson BI
    Acta Neuropathol Commun; 2019 May; 7(1):80. PubMed ID: 31109378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy.
    Heras-Garvin A; Weckbecker D; Ryazanov S; Leonov A; Griesinger C; Giese A; Wenning GK; Stefanova N
    Mov Disord; 2019 Feb; 34(2):255-263. PubMed ID: 30452793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.
    Kaji S; Maki T; Ishimoto T; Yamakado H; Takahashi R
    Transl Neurodegener; 2020; 9():7. PubMed ID: 32095235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.
    Kragh CL; Gysbers AM; Rockenstein E; Murphy K; Halliday GM; Masliah E; Jensen PH
    Neurobiol Dis; 2014 Mar; 63():171-83. PubMed ID: 24361600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy.
    Valera E; Ubhi K; Mante M; Rockenstein E; Masliah E
    Glia; 2014 Feb; 62(2):317-37. PubMed ID: 24310907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.